Licensing Agreement with Harmonic Discovery and UCSF for FLT3 Mutated AML Development Program
BioVentures has announced a licensing agreement with Harmonic Discovery and UC San Francisco for the development of a new drug
The post Licensing Agreement with Harmonic Discovery and UCSF for FLT3 Mutated AML Development Program first appeared on Bioventures.